Translational Research in Muscular Dystrophy (U01)
Funding Contact(s): John Porter, Ph.D.
Funding Categories: Channels, Synapses and Circuits
Brief Description:
The National Institute of Neurological Disorders and Stroke and the National Institute of Arthritis and Musculoskeletal and
Skin Diseases solicit applications for translational research projects in muscular dystrophy. Several emerging pathways to
treatment of muscular dystrophy show promise, ranging from palliative therapies that can markedly delay onset or progression
of the disease to genetic or stem cell approaches that may reverse or eliminate the condition. The objective of this initiative
is to encourage the pursuit of a broad range of translational research strategies for therapeutic development in muscular
dystrophy. This Program Announcement (PA) solicits applications for cooperative agreements that will support milestone-driven
projects focused on the identification and pre-clinical in vitro or animal testing of new therapeutics. Applications are
encouraged for translational research projects for any one or more of the muscular dystrophies.